Early solid tumor diagnosis through next-generation sequencing of cell-free DNA

Biomark Med. 2018 Nov;12(11):1197-1201. doi: 10.2217/bmm-2018-0269. Epub 2018 Oct 31.

Authors

Demosthenes E Ziogas^{1

2}, Ioannis D Kyrochristos^{1

3}, Efstathios G Lykoudis⁴, Dimitrios H Roukos^{1

3

5}

Affiliations

¹ Centre for Biosystems & Genome Network Medicine, Ioannina University, Ioannina, Greece.
² Department of Surgery, G Hatzikosta General Hospital, Ioannina, Greece.
³ Department of Surgery, University Hospital of Ioannina, Ioannina, Greece.
⁴ Department of Plastic Surgery, University Hospital of Ioannina, Ioannina, Greece.
⁵ Department of Systems Biology, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece.

PMID: 30379093
DOI: 10.2217/bmm-2018-0269

No abstract available

Keywords: cell-free DNA; early diagnosis; liquid biopsy; next-generation sequencing.

Publication types

Review

MeSH terms

Circulating Tumor DNA / blood*
Circulating Tumor DNA / genetics*
High-Throughput Nucleotide Sequencing*
Humans
Neoplasms / blood*
Neoplasms / diagnosis*
Neoplasms / genetics*

Substances

Circulating Tumor DNA